Biora Therapeutics, Inc. (BIORQ)

OTCMKTS · Delayed Price · Currency is USD

0.0000

0.00 (0.00%)

At close: Mar 16, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Medical Labs & Research	4.00K	305.00K	1.25M	162.00K	143.99M
Medical Labs & Research Growth	-98.69%	-75.54%	669.75%	-99.89%	12.51%
Total	4.00K	305.00K	1.25M	162.00K	143.99M
Total Growth	-98.69%	-75.54%	669.75%	-99.89%	12.51%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	4.00K	305.00K	1.25M	162.00K	143.99M
United States Growth	-98.69%	-75.54%	669.75%	-99.89%	12.51%
Total	4.00K	305.00K	1.25M	162.00K	143.99M
Total Growth	-98.69%	-75.54%	669.75%	-99.89%	12.51%

Source: S&P Global Market Intelligence.